| 2 | Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma. (Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Solórzano CC, Kim LT) Ann Surg Oncol 2020 May;27(5):1329-1337 64 Citations |
| 2 | Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma. (Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Kim LT, Solórzano CC) Ann Surg Oncol 2020 May;27(5):1338-1347 31 Citations |
| 1 | Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. (Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma) Thyroid 2015 Jun;25(6):567-610 2162 Citations |
| 1 | Failure to recognize multiple endocrine neoplasia 2B: more common than we think? (Wray CJ, Rich TA, Waguespack SG, Lee JE, Perrier ND, Evans DB) Ann Surg Oncol 2008 Jan;15(1):293-301 82 Citations |
| 1 | Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. (Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB) Arch Surg 2003 Apr;138(4):409-16; discussion 416 205 Citations |
| 1 | The surgical treatment of medullary thyroid carcinoma. (Evans DB, Fleming JB, Lee JE, Cote G, Gagel RF) Semin Surg Oncol 1999;16(1):50-63 61 Citations |
